ANDA 215343, held by Bright. Fluticasone Propionate.
As of Nov 16, 2026, ANDA 215343 (Fluticasone Propionate), held by Bright, was first approved by FDA on Sep 1, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 1, 2023 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fluticasone Propionate0.005% ยท ointment;topical | Fluticasone Propionate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters